5-Piperazin-1-ylpyrimidine is a heterocyclic organic compound characterized by the presence of a pyrimidine ring substituted with a piperazine moiety. This compound typically exhibits properties associated with both the pyrimidine and piperazine functional groups, such as potential basicity due to the nitrogen atoms in the piperazine ring. The structure allows for hydrogen bonding and interactions with biological targets, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. Its molecular structure contributes to its solubility in polar solvents, and it may exhibit moderate lipophilicity, influencing its bioavailability and pharmacokinetic properties. The compound's CAS number, 202135-70-4, is a unique identifier that facilitates its recognition in chemical databases and literature. Overall, 5-piperazin-1-ylpyrimidine is notable for its potential applications in drug discovery, particularly in areas targeting neurological or psychiatric conditions, owing to the piperazine's known activity in various receptor interactions.

5-piperazin-1-ylpyrimidine

202135-70-4: 5-Piperazin-1-ylpyrimidine is a heterocyclic organic compound characterized by the presence of a pyrimidine ring substituted with a piperazine moiety. This compound typically exhibits properties associated with both the pyrimidine and piperazine functional groups, such as potential basicity due to the nitrogen atoms in the piperazine ring. The structure allows for hydrogen bonding and interactions with biological targets, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. Its molecular structure contributes to its solubility in polar solvents, and it may exhibit moderate lipophilicity, influencing its bioavailability and pharmacokinetic properties. The compound's CAS number, 202135-70-4, is a unique identifier that facilitates its recognition in chemical databases and literature. Overall, 5-piperazin-1-ylpyrimidine is notable for its potential applications in drug discovery, particularly in areas targeting neurological or psychiatric conditions, owing to the piperazine's known activity in various receptor interactions.

CAS 202135-70-4

5-piperazin-1-ylpyrimidine

5-(Piperazin-1-yl)pyrimidine

Ref: IN-DA002839

5-(Piperazin-1-yl)pyrimidine hydrochloride

Ref: 10-F237178